AZAD PHARMA AG has a total of 36 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and basic materials chemistry are EPICEPT INC, AIDANCE SKINCARE AND TOPICAL SOLUTIONS LLC and AMERICAN SILVER LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Canada | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 3 | |
#5 | China | 3 | |
#6 | Republic of Korea | 3 | |
#7 | United States | 3 | |
#8 | United Kingdom | 2 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Basic materials chemistry | |
#4 | Medical technology | |
#5 | Organic fine chemistry | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Baronian Mihran | 26 |
#2 | Carli Fabio | 19 |
#3 | Chiellini Elisabetta | 18 |
#4 | Schmid Rene | 10 |
#5 | Baehler Ernest | 5 |
#6 | Barseghyan Karine | 3 |
#7 | Khov-Tran Van Van | 3 |
#8 | Hambardzumyan Davit | 3 |
#9 | Gevorgyan Grigor | 3 |
#10 | Nerkararyan Kristine | 3 |
Publication | Filing date | Title |
---|---|---|
GB202001121D0 | Process for there synthesis of buprenorphine | |
EP3593862A1 | Electrochemically activated salt solution | |
GB201804005D0 | New polymorph and new path to synthesize tafamidis | |
EP2985038A1 | Lyophilized API preparation | |
EP2204167A1 | Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules | |
WO2009013019A2 | Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions | |
EP1985298A1 | Ophtalmic oil-in-water emulsions containing prostaglandins |